Showing results (1131-1140 of 1,396) with videos related to

Sort By:
Pageof 140
JCO Precision Oncology|March 30, 2023
Efficacy of Targeted Trials and Signaling Pathway Landscape in Advanced Gastrointestinal Cancers From SCRUM-Japan GI-SCREEN: A Nationwide Genomic Profiling ProgramYoshiaki Nakamura, Riu Yamashita, Wataru Okamoto, et al.
JCO Precision Oncology|April 26, 2023
Association Between Biomarkers and Clinical Outcomes of Pembrolizumab Monotherapy in Patients With Metastatic Triple-Negative Breast Cancer: KEYNOTE-086 Exploratory AnalysisSherene Loi, Roberto Salgado, Peter Schmid, et al.
JCO Precision Oncology|May 10, 2023
The Maine Cancer Genomics Initiative: Implementing a Community Cancer Genomics Program Across an Entire Rural StateJens Rueter, Eric C Anderson, Leah C Graham, et al.
JCO Precision Oncology|May 17, 2023
MLH1 Loss in Primary Prostate CancerSanaz Nourmohammadi Abadchi, Laura A Sena, Emmanuel S Antonarakis, et al.
JCO Precision Oncology|August 25, 2020
Pathogenic Variants in Cancer Predisposition Genes and Prostate Cancer Risk in Men of African AncestryMarco Matejcic, Yesha Patel, Jenna Lilyquist, et al.
JCO Precision Oncology|January 15, 2019
Analysis of NTRK Alterations in Pan-Cancer Adult and Pediatric Malignancies: Implications for NTRK-Targeted TherapeuticsRyosuke Okamura, Amélie Boichard, Shumei Kato, et al.
JCO Precision Oncology|January 16, 2020
Decision-Making Preferences About Secondary Germline Findings That Arise From Tumor Genomic Profiling Among Patients With Advanced CancersJada G Hamilton, Elyse Shuk, Margaux Genoff Garzon, et al.
JCO Precision Oncology|September 11, 2020
Window-of-Opportunity Study of Valproic Acid in Breast Cancer Testing a Gene Expression BiomarkerAdam L Cohen, Leigh Neumayer, Ken Boucher, et al.
JCO Precision Oncology|September 11, 2020
Communicating About Precision OncologyDaniel C McFarland, Elizabeth Blackler, Smita Banerjee, et al.
JCO Precision Oncology|September 11, 2020
High Expression of FGD3, a Putative Regulator of Cell Morphology and Motility, Is Prognostic of Favorable Outcome in Multiple CancersScooter Willis, Yuliang Sun, Mark Abramovitz, et al.
Pageof 140